Brown Brothers Harriman & Co’s Amicus Therapeutics FOLD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-559	Closed	-$8.08K	–	1844
2026 Q1	$8.08K	Buy	559 +86	+18%	+$1.23K	﹤0.01%	1394
2025 Q4	$6.74K	Buy	+473	New	+$4.65K	﹤0.01%	1437
2019 Q2	–	Sell	-1,105	Closed	-$15K	–	1141
2019 Q1	$15K	Buy	+1,105	New	+$13.5K	﹤0.01%	776

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Brown Brothers Harriman & Co's FOLD Position: Q2 2026 in Review

Brown Brothers Harriman & Co sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 559 shares — an estimated $8.08K sold.

Brown Brothers Harriman & Co first reported a position in FOLD in Q1 2019 and held it in 3 quarters. The position peaked at $15K in Q1 2019. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Brown Brothers Harriman & Co reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Brown Brothers Harriman & Co sold 559 Amicus Therapeutics shares in Q2 2026, an estimated $8.08K.
Brown Brothers Harriman & Co first reported a position in Amicus Therapeutics in Q1 2019 and held it in 3 quarters.
Brown Brothers Harriman & Co's Amicus Therapeutics position peaked at $15K in Q1 2019.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.